Allergan plc (NYSE:AGN) [Trend Analysis] retains strong position in active trade, as shares scoring -0.25% to $211.33 in a active trade session, while looking at the shares volume, around 153880 shares have changed hands in this session. Allergan plc (AGN) disclosed that U.S. FDA has authorized the company’s supplemental New Drug Application (sNDA) to update the label for AVYCAZ with clinical data from two Phase 3 trials supporting the indication to treat patients with complicated urinary tract infections (cUTI), including pyelonephritis, caused by designated susceptible Gram-negative microorganisms.
In Trial 1, known as RECAPTURE, AVYCAZ was non-inferior to doripenem with regard to both primary endpoints. In Trial 2, known as REPRISE, AVYCAZ demonstrated a higher combined clinical and microbiological cure rate vs. best accessible therapy (BAT), including meropenem, imipenem, doripenem, and colistin. Additionally, both trials included a subset of patients with infections caused by pathogens producing certain ESBL groups and AmpC beta-lactamases in which the clinical and microbiological cure rates were similar to the overall results.
The firm has institutional ownership of 89.40%, while insider ownership included 0.10%. AGN attains analyst recommendation of 2.00 with week’s performance of -1.37%. Investors looking further ahead will note that the Price to next year’s EPS is 18.78%.
Shares of Varian Medical Systems, Inc. (NYSE:VAR) [Trend Analysis] swings enthusiastically in regular trading session, it a gain of 0.03% to close at $77.70. Varex Imaging Corporation (NASDAQ:VREX) reported that its spin-off from Varian Medical Systems (VAR) has been successfully completed. The common stock of Varex Imaging, a new independent public company, will begin trading “regular way” recently on the Nasdaq Global Select Market under the ticker symbol “VREX”.
Under the terms of the previously reported separation, Varian stockholders received 0.4 of a share of Varex stock for every one share of Varian stock they held as of the record date of January 20, 2017. Varex shares were distributed at 12:01 am Pacific Time on January 28, 2017 in a distribution that is intended to be tax-free for U.S. federal income tax purposes. Varex has approximately 38 million shares outstanding. The stock is going forward its fifty-two week low with 6.18% and lagging behind from its 52-week high price with -27.18%. VAR last month stock price volatility remained 1.83%.